Search clinical trials for: 2 nucleoside reverse transcriptase inhibitors (NRTIs)
Total 2243 results
-
PfizerTerminatedHIV-1Spain, United Kingdom, Malaysia, United States, Portugal, Brazil, Germany, Italy, Poland, Puerto Rico, South Africa, Taiwan, Ukraine
-
ViiV HealthcareGlaxoSmithKline; Janssen PharmaceuticalsActive, not recruitingHIV Infections | Infection, Human Immunodeficiency VirusGermany, Spain, France, United States, Canada, Australia, Korea, Republic of, Italy, South Africa, Russian Federation, Argentina, Mexico, Sweden
-
Assembly BiosciencesArbutus Biopharma CorporationTerminatedChronic Hepatitis BAustralia, Canada, Bulgaria, New Zealand
-
Assistance Publique - Hôpitaux de ParisCompleted
-
University of MinnesotaAmerican College of Clinical PharmacyCompletedHIV/AIDS | Menopause | Inflammation VaginaUnited States
-
AvexaCompletedHIV InfectionsAustralia
-
Bristol-Myers SquibbCompleted
-
Gilead SciencesCompletedChronic Hepatitis BUnited States
-
Mansoura UniversityCompleted
-
National Taiwan University HospitalTerminatedHBsAg-positive Renal Allograft Recipients
-
GlaxoSmithKlineCompleted
-
NovartisNovartis PharmaceuticalsCompletedChronic Hepatitis BChina
-
Therapeutic ConceptsCompleted
-
NovartisNovartis PharmaceuticalsCompletedHepatitis BCanada, France, United States, China
-
Novartis PharmaceuticalsCompletedHepatitis | Hepatitis B, Chronic | CirrhosisUnited States, France, United Kingdom, Taiwan, Spain, Korea, Republic of, Singapore, New Zealand, Thailand, Germany, Israel, Russian Federation, Canada, China, Latvia, Turkey, Australia, India, Malaysia, Poland, Vietnam
-
AIDS Clinical Trials GroupNational Institute of Allergy and Infectious Diseases (NIAID); Merck Sharp... and other collaboratorsCompletedHIV-1 InfectionKenya, Brazil, South Africa, Uganda, Zimbabwe, India, Malawi, Haiti, Thailand, Peru
-
NovartisNovartis PharmaceuticalsCompletedChronic Hepatitis BUnited States, United Kingdom, Spain, Korea, Republic of, Turkey, Thailand
-
National Institute of Allergy and Infectious Diseases...Bristol-Myers Squibb; Glaxo WellcomeCompletedHIV InfectionsUnited States, Puerto Rico
-
University of California, Los AngelesUniversity of Cape TownActive, not recruitingHIV-I InfectionSouth Africa
-
Yonsei UniversityPusan National University HospitalCompletedHepatitis B, ChronicKorea, Republic of
-
National Cancer Institute (NCI)CompletedAcquired Immunodeficiency Syndrome | AIDS-Related ComplexUnited States
-
Janssen Sciences Ireland UCActive, not recruitingHIV Infections | HIV-1United States, France, Spain, South Africa, Canada, Argentina, Thailand, Brazil, Romania, Panama, Puerto Rico
-
University of LiverpoolJanssen Pharmaceutica; Yaounde Central Hospital; Chantal Biya International Reference...Completed
-
Janssen R&D IrelandCompletedHuman Immunodeficiency Virus (HIV) InfectionFrance, Ukraine, United States, Mexico, Romania, South Africa, Peru, Argentina, Puerto Rico, Russian Federation, Guatemala
-
ViiV HealthcareCompletedHIV Infection | Infection, Human Immunodeficiency Virus IUnited States, Puerto Rico, Costa Rica, Panama
-
CONRADNational Institute of Allergy and Infectious Diseases (NIAID); National Institute...Completed
-
Indiana UniversityTibotec Therapeutics, a Division of Ortho Biotech Products, L.P., USACompletedHIV Infections | Inflammation | Insulin Resistance | Endothelial Function | LipidsUnited States
-
Gilead SciencesCompleted
-
Tibotec Pharmaceuticals, IrelandCompleted
-
National Institute of Allergy and Infectious Diseases...CompletedSafety and Effectiveness of Giving Indinavir Plus Stavudine Plus Lamivudine to HIV-Infected ChildrenHIV InfectionsUnited States, Puerto Rico
-
ViiV HealthcareGlaxoSmithKline; Janssen PharmaceuticalsCompleted
-
Tibotec Pharmaceuticals, IrelandCompletedHIV-1United States, Belgium, Germany, Taiwan, Spain, Mexico, Turkey, Canada, Netherlands, Denmark, Greece, Sweden, Korea, Republic of, Russian Federation, Puerto Rico, Luxembourg
-
Tibotec Pharmaceuticals, IrelandCompleted
-
Tibotec Pharmaceuticals, IrelandCompleted
-
University of MinnesotaNational Institute of Allergy and Infectious Diseases (NIAID); Makerere University and other collaboratorsCompletedHIV Infections | AIDS | Cryptococcal MeningitisUganda, South Africa
-
National Institute of Allergy and Infectious Diseases...Completed
-
National Institute of Allergy and Infectious Diseases...Microbicide Trials NetworkCompletedAdherence and Acceptability to and Blood Levels of Tenofovir Gel and Tablets in HIV Uninfected WomenHIV InfectionsUnited States, Uganda, South Africa
-
CONRADGilead Sciences; International Partnership for Microbicides, Inc.CompletedHIV InfectionsUnited States, Dominican Republic
-
ANRS, Emerging Infectious DiseasesViiV HealthcareCompleted
-
National Institute of Allergy and Infectious Diseases...Eunice Kennedy Shriver National Institute of Child Health and Human Development...Completed
-
IRCCS Eugenio MedeaUniversity of Rome Tor VergataCompleted
-
Gilead SciencesCompleted
-
Tibotec Pharmaceuticals, IrelandCompleted
-
Tibotec Pharmaceuticals, IrelandCompleted
-
Gilead SciencesTerminated
-
Uijeongbu St. Mary HospitalUnknownProportion of Patients With a Sustained Virological Response (Serum HBV DNA <20 IU/mL) at Week 48
-
GlaxoSmithKlineCompletedHIV InfectionUnited States, Puerto Rico
-
Tibotec Pharmaceuticals, IrelandCompletedHIV-1United States, Canada, France, Belgium, Germany, Spain, Argentina, Chile, Panama, Brazil, Puerto Rico, Thailand, Mexico, Australia